Micro and nanoparticles

 

Nanoparticles possess several advantages in comparison to large particles which allow enhanced forms of drugs to be produced.

Many drugs when produced in nanoparticulate form will exhibit one or more of the following advantages:



Surface Area PDF Print E-mail

A reduction in particle size generates a corresponding increase in surface area. A size reduction form a ‘standard’ 5 µm particle to 0.2 µm nanoparticles will increase the nominal surface area by a factor of 25. A larger surface area creates a greater possibility for dissolution in a solvent, which can lead to significantly increased dissolution rates.

 


Contact us

Activery Locations
Phone: +34 935 820 152
Fax: +34 935 801 354
E-mail: contactus @ activery.com

R&D facilities
Centre d'empreses de noves tecnologies
Parc Tecnològic del Vallès
08290 Cerdanyola del Vallès
Barcelona
Spain

 

Head office
C/Berlin 50
08029 Barcelona
Spain

Activery : the amorphization and particle production company